Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations
NCT: NCT03243019 · RECRUITING
광고
NCT IDNCT03243019
상태RECRUITING
시작일2018-06-25
SponsorUniversity Hospital, Lille (OTHER)
First posted
Last updated
간략 요약
To evaluate the efficacy of Rapamycin in extended cervicofacial lymphatic malformations in pediatric patients. Rapamycin is administered oral for a 6 month period. The success rate is determined by volume reduction superior to 1/5e of the initial volume measured by MRI, impact on QOL and reduction of bleeding in case of mucosal involvement.
공식 출처
ClinicalTrials.gov에서 보기 →데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.